These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28279155)

  • 1. Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications.
    Connors WJ; Rabie HH; Figueiredo RL; Holton DL; Parkins MD
    BMC Infect Dis; 2017 Mar; 17(1):202. PubMed ID: 28279155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
    Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
    Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
    Yong C; Fisher DA; Sklar GE; Li SC
    Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
    Conant MM; Erdman SM; Osterholzer D
    J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.
    Yadav K; Suh KN; Eagles D; Thiruganasambandamoorthy V; Wells GA; Stiell IG
    Am J Emerg Med; 2019 Nov; 37(11):2008-2014. PubMed ID: 30824277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
    González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
    Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient parenteral antibiotic therapy (OPAT) and inpatient treatment strategies for emergency department patients with cellulitis: a cost analysis.
    Yadav K; Kumar S; Chhabra S; Rosenberg H; Eagles D; Suh KN; Ohle R; Nath A; Thavorn K
    CJEM; 2022 Aug; 24(5):520-528. PubMed ID: 35675027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
    Chan M; Ooi CK; Wong J; Zhong L; Lye D
    BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient parenteral antibiotic therapy (OPAT) in Asia: missing an opportunity.
    Fisher D; Michaels J; Hase R; Zhang J; Kataria S; Sim B; Tsang JK; Pollard J; Chan M; Swaminathan S
    J Antimicrob Chemother; 2017 Apr; 72(4):1221-1226. PubMed ID: 28077673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
    Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
    Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
    Mansour O; Heslin J; Townsend JL
    J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.
    Chapman AL; Dixon S; Andrews D; Lillie PJ; Bazaz R; Patchett JD
    J Antimicrob Chemother; 2009 Dec; 64(6):1316-24. PubMed ID: 19767623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OPAT: proof of concept in a peripheral Belgian hospital after review of the literature.
    Smismans A; Vantrappen A; Verbiest F; Indevuyst C; Van den Poel B; von Winckelmann S; Peeters A; Ombelet S; Lybeert P; Heremans A; Frans E; Ho E; Frans J
    Acta Clin Belg; 2018 Aug; 73(4):257-267. PubMed ID: 29385901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilizing a Modified Care Coordination Measurement Tool to Capture Value for a Pediatric Outpatient Parenteral and Prolonged Oral Antibiotic Therapy Program.
    Vaz LE; Farnstrom CL; Felder KK; Guzman-Cottrill J; Rosenberg H; Antonelli RC
    J Pediatric Infect Dis Soc; 2018 May; 7(2):136-142. PubMed ID: 28419343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and cost-effectivity analysis of outpatient parenteral antimicrobial therapy unit in infectious disease clinical practices: Turkey perspective.
    Bastug A; Oksuz E; Kazancioglu S; Malhan S; Ozbay BO; Bodur H
    Int J Clin Pract; 2021 Jun; 75(6):e14147. PubMed ID: 33709495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost minimization analysis of outpatient parenteral/oral antibiotic therapy at a trauma hospital: Public health system.
    Loesch GH; Cruz JAW; Gasparetto J; Oliveira DDS; Telles JP; Tuon FF
    Infect Control Hosp Epidemiol; 2021 Dec; 42(12):1445-1450. PubMed ID: 33618784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.
    Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M
    J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.
    Bazaz R; Chapman AL; Winstanley TG
    J Antimicrob Chemother; 2010 Jul; 65(7):1510-3. PubMed ID: 20460397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.